Manufacturer record

Swiss Garnier Genexiaa Sciences Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by Swiss Garnier Genexiaa Sciences Pvt. Ltd (Sikkim) were declared Not of Standard Quality in April 2022. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: SGUL0191, Alphacept ? D8 (Silodosin and Dutasteride Tablets) (exp Aug 2023). CDL Kolkata (CDSCO lab) found it not of standard quality: Related Substances of Silodosin. Listed in the April 2022 alert.

Records by type

2 records linked to Swiss Garnier Genexiaa Sciences Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Apr 2022 to Apr 2022

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2022
1
Products affected
Related substances
Most common failure
Apr 2022
Latest alert

Flagged batches per year

2022 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Alphacept ? D8 (Silodosin and Dutasteride Tablets) Batch SGUL0191Mfg Sep 2021 · Exp Aug 2023 Related Substances of SilodosinRelated substances CDL KolkataCDSCO lab Apr 2022
Alphacept - D4 (Silodosin and Dutasteride Tablets) Batch SGUL0192Mfg Sep 2021 · Exp Aug 2023 Related Substances of SilodosinRelated substances CDL KolkataCDSCO lab Apr 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.